Evaluation of activity of recombinant lysostaphin against isolates of meticillin-resistant Staphylococcus aureus from Indian hospitals

J Med Microbiol. 2014 May;63(Pt 5):763-766. doi: 10.1099/jmm.0.070557-0. Epub 2014 Mar 12.

Authors

Ashwani Kumar^{1

2}, Inshad Ali Khan², Parduman Raj Sharma³, Sumathy K¹, Krishna M Ella¹

Affiliations

¹ R & D Department, Bharat Biotech International Ltd, Genome Valley, Shameerpet Mandal, Hyderabad, India.
² Clinical Microbiology Division, Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India.
³ Cancer Pharmacology Division, Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India.

PMID: 24623634
DOI: 10.1099/jmm.0.070557-0

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Administration, Topical
Animals
Anti-Bacterial Agents / pharmacology*
Anti-Bacterial Agents / therapeutic use
Bacterial Load
Biofilms / drug effects
Disease Models, Animal
Hospitals
Humans
India
Lysostaphin / pharmacology*
Lysostaphin / therapeutic use
Methicillin-Resistant Staphylococcus aureus / drug effects*
Methicillin-Resistant Staphylococcus aureus / isolation & purification*
Methicillin-Resistant Staphylococcus aureus / physiology
Mice
Microbial Sensitivity Tests
Microscopy, Electron, Scanning
Recombinant Proteins / pharmacology
Recombinant Proteins / therapeutic use
Staphylococcal Infections / microbiology*
Staphylococcal Skin Infections / drug therapy
Treatment Outcome

Substances

Anti-Bacterial Agents
Recombinant Proteins
Lysostaphin